Tirzepatide has received approval for use in patients with T2D following several phase 3 studies testing and demonstrating its marked anti-hyperglycemic efficacy and positive actions on multiple cardiovascular risk factors, associated with an excellent safety profile [2, 3]
This section reviews alterations in muscle mass, muscle quality, and their underlying mechanisms during GLP-1 RA therapy, as illustrated in Fig
1 This comes as Novo Nordisk and Eli Lilly continue to aggressively challenge compounded versions of their GLP-1 medications
Other companion solution providers should monitor progress of these solutions closely and adopt
Navigating the Consultation: Your Fertility Roadmap If youre considering GLP-1s as part of your fertility journey, working with a multidisciplinary teaman endocrinologist, OB-GYN, and registered dietitiancan be invaluable